by QME | Sep 11, 2020 | News
We’re delighted to share some fantastic news from our partner, Queen Mary University of London. On September 9th, Postdoctoral Research Associate Khai DQ Nguyen was awarded the Future Innovator award at the 2020 Knowledge Transfer Partnerships Best of the Best...
by QME | Sep 10, 2020 | Blog
Barts Cancer Institute (BCI), supported by the Pancreatic Cancer Research Fund, are working with Spirogen and ADC Therapeutics in finding a cure for pancreatic cancer from an unlikely source – foot and mouth disease. The virus, which wiped out more than six million...
by QME | Aug 20, 2020 | Blog
August was an exciting month at Barts Life Sciences as we selected projects for our second cohort of the CAP-AI programme. Watch this space for more details on these projects and how you can get involved this autumn. We’re also delighted to be...
by QME | Aug 13, 2020 | Blog
Queen Mary University of London has developed the world’s first urine test for detecting pancreatic cancer, potentially improving survival rates by as much as 60%. The test has been developed to spot warning signs of the disease in the earliest stages. Often called...
by QME | Jul 22, 2020 | Blog
From the desk of CAP-AI data scientist Andrew Bard: Project title: Prediction of aortic changes from surveillance magnetic resonance imaging in congenital ascending aortic aneurysm The CAP-AI programme enables a wide range of projects, and facilitates...
